Tomáš Milota
Charles University(CZ)University Hospital in Motol(CZ)
Publications by Year
Research Areas
Immunodeficiency and Autoimmune Disorders, SARS-CoV-2 and COVID-19 Research, Immune Cell Function and Interaction, Blood disorders and treatments, Cystic Fibrosis Research Advances
Most-Cited Works
- → Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study(2016)438 cited
- → Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry(2018)178 cited
- → Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations(2021)162 cited
- → Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?(2023)109 cited
- → Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation(2018)79 cited
- → IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives(2021)66 cited
- → CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID(2019)60 cited
- → Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity(2023)59 cited
- → Principles and Challenges in anti-COVID-19 Vaccine Development(2021)57 cited
- → Hyper‐IgE in the allergy clinic––when is it primary immunodeficiency?(2018)53 cited